Red Violet Q3 2026: 20% Revenue Growth and Record Cash Flow, but Key Thesis Metrics Remain Unverified

What happened

Red Violet reported Q3 2026 revenue of $27.8 million, up 20% year-over-year, marking a record and meeting the top-line growth threshold set by the prior DeepValue report's 'increase if' condition. Operating cash flow also hit a record $12.7 million, suggesting strong cash conversion and underlying profitability. However, the press release omitted key metrics the prior report flagged as essential for a rating upgrade: adjusted EBITDA margin (needed ≥35%), contractual revenue mix (watch for <70%), and any named public-sector wins via the Carahsoft/GSA channel. Without those disclosures, the result confirms continued execution on growth and cash generation but leaves the public-sector growth pillar and mix stability unverified. Thus, the news is positive on headline numbers but insufficient to resolve the WAIT rating's primary concerns.

Implication

The 20% revenue growth and record operating cash flow support the base case, but they do not address the premium valuation's dependence on durable growth quality. Without a disclosed adjusted EBITDA margin, it is unclear whether profitability remained above the 35% threshold needed to justify an upgrade. The silence on contractual revenue mix and public-sector wins means two of the three 'what changes the call' conditions remain unconfirmed, leaving the thesis unchanged. Given the thin trading liquidity and high multiple (P/E ~51x as of the last report), the stock could re-rate downward if these missing details disappoint when the 10-Q is filed. Therefore, investors should maintain a WAIT stance, using the next 10-Q to check for contractual mix above 70% and any public-sector disclosures before considering adding to positions.

Thesis delta

The thesis remains WAIT. Q3 2026 revenue growth of 20% meets the top-line condition for an upgrade, but the lack of color on adjusted EBITDA margin and public-sector wins prevents a shift. The report's core concerns about revenue quality and public-sector validation are not addressed by this release, so the rating stays WAIT.